Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL PD 1 W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIANEAL PD 1 W DEXTROSE 3 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIANEAL PD 1 W DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIANEAL PD 1 W DEXTROSE 3 5 IN PLASTIC CONTAINER.
DIANEAL PD-1 W/ DEXTROSE 2.5% IN PLASTIC CONTAINER vs DIANEAL PD-1 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that serves as a caloric agent and increases osmotic pressure to facilitate ultrafiltration during peritoneal dialysis. The osmotic gradient created by dextrose drives the removal of waste products and excess fluid from the blood across the peritoneal membrane.
Dianeal PD-1 with dextrose 3.5% is a peritoneal dialysis solution that uses dextrose as an osmotic agent to create an osmotic gradient across the peritoneal membrane, facilitating the removal of waste products (urea, creatinine) and excess fluid from the blood into the dialysate.
Intraperitoneal administration: 2 L (or appropriate volume based on body size) infused over 10-20 minutes, dwell time 4-6 hours, then drain; typically 4 exchanges per 24 hours.
2-3 L intraperitoneally, dwell time 4-6 hours, 4-5 exchanges per day
None Documented
None Documented
Not applicable; dextrose is rapidly metabolized with a half-life of minutes; peritoneal dialysis dwell time is typically 4-6 hours.
Glucose: 1.5–2 hours (intraperitoneal administration leading to systemic absorption); clinical context: prolonged in renal impairment due to decreased clearance of metabolic products, but glucose itself is rapidly metabolized.
Renal: 100% (dextrose is fully metabolized; water and electrolytes are removed via peritoneal dialysis, not excreted unchanged).
Renal (virtually 100% of absorbed dextrose and metabolites); peritoneal dialysis removes glucose and metabolic byproducts, but significant elimination occurs via transperitoneal absorption into systemic circulation followed by renal excretion (in patients with residual renal function). In anuric patients, glucose is metabolized and eliminated as CO2 and water, with minimal direct excretion.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution